Immune recognition components

Immune recognition components comprise a diverse array of molecules, including Pattern Recognition Receptors (PRRs), T-cell receptors (TCRs), and Major Histocompatibility Complex (MHC) molecules, which are fundamental to the immune system's ability to identify pathogens and abnormal self-cells (Janeway's Immunobiology, 9th ed.). PRRs, such as Toll-like receptors (TLRs), recognize pathogen-associated molecular patterns (PAMPs), triggering innate immune responses (NCBI, Bookshelf, NBK27144). TCRs and B-cell receptors (BCRs) provide the specificity required for adaptive immunity by recognizing unique antigens presented by MHC molecules (UniProt, P04234). Dysregulation of these recognition systems is central to the pathogenesis of autoimmune diseases, where self-tissues are misidentified as foreign, and cancer, where malignant cells evade detection (Nature Reviews Immunology, 2020). Therapeutic interventions targeting these components include TLR agonists like Imiquimod for viral infections and checkpoint inhibitors like Nivolumab that modulate TCR signaling in oncology (PubChem, CID 3949). However, manipulating these pathways requires careful management to avoid systemic toxicity, such as cytokine release syndrome or severe autoimmunity (StatPearls, NBK541061). Because this term describes a functional category rather than a single molecular entity, it encompasses a wide range of distinct protein families with varying structures and signaling mechanisms.

Other names

Pattern recognition receptorsAntigen recognition moleculesImmune sensorsMHC moleculesT-cell receptorsB-cell receptorsImmune recognition molecules

Modulation of immune signaling through the activation or inhibition of receptors involved in pathogen sensing and antigen recognition.